Australia markets close in 21 minutes

Medlab Clinical Limited (MDC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
6.600.00 (0.00%)
As of 11:59AM AEST. Market open.
Full screen
Previous close6.60
Open6.60
Bid0.00 x 3519200
Ask0.00 x 165200
Day's range6.60 - 6.60
52-week range6.55 - 11.79
Volume49
Avg. volume0
Market cap15.071M
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
EPS (TTM)-547.50
Earnings date29 Oct 2023 - 30 Oct 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    MEDLAB ANNOUNCES FAVOURABLE INTERIM READOUT OF NANABIS™ REAL-WORLD EVIDENCE (RWE) MEDCARE STUDY

    N=1,172 Australian pain patientsDatapoints collected from commencing NanaBis™ (baseline) up to month 1255% improvement in pain relief75% of patients reduced their opioid use31% Improvements in Quality of Life as it relates to pain interference92% of patients with bone metastasis from cancer had reduced their pain severity and pain interference (Quality of Life) scores at 6-monthsNew “ENHANCE” study expects to onboard March 2023 Sydney, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Medlab Clinical Ltd (ASX:M

  • Simply Wall St.

    Medlab Clinical Full Year 2022 Earnings: Beats Expectations

    Medlab Clinical ( ASX:MDC ) Full Year 2022 Results Key Financial Results Revenue: AU$1.54m (up 110% from FY 2021). Net...